These studies also showed that fusing an unrelated IDR of the FUS gene or an artificial peptide containing 39 FG repeats to known NUP98 fusion partners like KDM5A and HOXA9 was sufficient to activate a leukemia-associated transcriptional program and induce leukemia in vivo. The gene discussed is KDM5A; the disease is leukemia.